Martin Müller

Further involvements

• 07/03/2023

  • Poster
  • P008

  PANHPVAX: Study design for dose titration of two first-in-human molecules (human papillomavirus L2 antigen with cyclic di-AMP) in a single vaccine trial

   Disease models, drug development, Immunopharmacology / inflammation / anti-infectives
• 08/03/2023

  17:30 – 17:45 10 Min. 5 Min.

  • Oral presentation
  • 64

  Improving chemosensitivity in cancer - A novel role for Two Pore Channel 2

   Cancer pharmacology , Ion channels and membrane transporters